Gene · 9436
Papers3,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Natural killer cells in the central nervous system. | Cell Commun Signal | 2023 | 38031097 | PubTator, text mining | PubMed |
| Charting a killer course to the solid tumor: strategies to recruit and activate NK cells in the tumor microenvironment. | Front Immunol | 2023 | 38022679 | PubTator, text mining | PubMed |
| NK cell exhaustion in the tumor microenvironment. | Front Immunol | 2023 | 38022646 | PubTator, text mining | PubMed |
| Cancer-associated mesenchymal stem/stromal cells: role in progression and potential targets for therapeutic approaches. | Front Immunol | 2023 | 38022534 | PubTator, text mining | PubMed |
| Anti-TIM3 chimeric antigen receptor-natural killer cells from engineered induced pluripotent stem cells effectively target acute myeloid leukemia cells. | Cancer Cell Int | 2023 | 38012684 | PubTator, text mining | PubMed |
| Exploiting innate immunity for cancer immunotherapy. | Mol Cancer | 2023 | 38008741 | PubTator, text mining | PubMed |
| Therapeutic avenues for γδ T cells in cancer. | J Immunother Cancer | 2023 | 38007241 | PubTator, text mining | PubMed |
| In Vivo Treatment with Insulin-like Growth Factor 1 Reduces CCR5 Expression on Vaccine-Induced Activated CD4+ T-Cells. | Vaccines (Basel) | 2023 | 38005994 | PubTator, text mining | PubMed |
| Immune-Cell-Based Therapy for COVID-19: Current Status. | Viruses | 2023 | 38005826 | PubTator, text mining | PubMed |
| Early-to-mid stage idiopathic Parkinson's disease shows enhanced cytotoxicity and differentiation in CD8 T-cells in females. | Nat Commun | 2023 | 37985656 | PubTator, text mining | PubMed |
| The Vγ4/butyrophilin conspiracy: novel role of intraepithelial γδ T cells in chronic inflammatory bowel disease. | Signal Transduct Target Ther | 2023 | 37980330 | PubTator, text mining | PubMed |
| Extracellular vesicle-based liquid biopsy biomarkers and their application in precision immuno-oncology. | Biomark Res | 2023 | 37978566 | PubTator, text mining | PubMed |
| Abundant binary promoter switches in lineage-determining transcription factors indicate a digital component of cell fate determination. | Cell Rep | 2023 | 37976160 | PubTator, text mining | PubMed |
| Immune responses elicited by ssRNA(-) oncolytic viruses in the host and in the tumor microenvironment. | J Cancer Metastasis Treat | 2023 | 37974615 | PubTator, text mining | PubMed |
| Early innate cell interactions with Mycobacterium tuberculosis in protection and pathology of tuberculosis. | Front Immunol | 2023 | 37965344 | PubTator, text mining | PubMed |
| An immunomodulating peptide with potential to suppress tumour growth and autoimmunity. | Sci Rep | 2023 | 37957274 | PubTator, text mining | PubMed |
| SARS-CoV-2 Nsp8 suppresses MDA5 antiviral immune responses by impairing TRIM4-mediated K63-linked polyubiquitination. | PLoS Pathog | 2023 | 37956198 | PubTator, text mining | PubMed |
| Characterizing hepatocellular carcinoma stem markers and their corresponding susceptibility to NK-cell based immunotherapy. | Front Immunol | 2023 | 37954598 | PubTator, text mining | PubMed |
| Bcl6 is a subset-defining transcription factor of lymphoid tissue inducer-like ILC3. | Cell Rep | 2023 | 37950867 | PubTator, text mining | PubMed |
| Boosting cytotoxicity of adoptive allogeneic NK cell therapy with an oncolytic adenovirus encoding a human vIL-2 cytokine for the treatment of human ovarian cancer. | Cancer Gene Ther | 2023 | 37949944 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9436/papers?page=9